Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An edge β-strand mutation turns ubiquitin into a pore-forming amyloid.

Protein science : a publication of the Protein Society·2026
Same author

A mild colloidal strategy for controlling the morphology of reduced graphene oxide-Ag nanowire hybrids.

Nanoscale·2026
Same author

Correction to "First-In-Class Thiosemicarbazone Metal Complexes Targeting the Sigma-2 Receptor (S2R) as an Innovative Strategy against Pancreatic Cancer".

Journal of medicinal chemistry·2026
Same author

Protective Functions of β-Alanyl-L-Histidine and Glycyl-L-Histidyl-L-Lysine Glycoconjugates and Copper in Concert.

Antioxidants (Basel, Switzerland)·2025
Same author

Carnosine Biofunctionalized Hydroxyapatite Induces Copper-Driven Osteogenesis and Angiogenesis, Strengthening Its Bone Regenerative Capacities.

ACS biomaterials science & engineering·2025
Same author

Retraction notice to "Protective Effect of a new Hyaluronic Acid -Carnosine Conjugate on the Modulation of the Inflammatory Response in Mice Subjected to Collagen-Induced Arthritis" [Biomed. Pharmacother. 125 (2020) 110023].

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2025

Related Experiment Video

Updated: Jun 20, 2026

In Vitro Analysis of E3 Ubiquitin Ligase Function
06:06

In Vitro Analysis of E3 Ubiquitin Ligase Function

Published on: May 14, 2021

Copper-triggered aggregation of ubiquitin.

Fabio Arnesano1, Simone Scintilla, Vincenza Calò

  • 1Dipartimento Farmaco-Chimico, University of Bari A. Moro, Bari, Italy.

Plos One
|September 17, 2009
PubMed
Summary

Copper binding induces ubiquitin aggregation, forming structures similar to those seen in neurodegenerative diseases like Parkinson's and Alzheimer's. This ubiquitin aggregation may be a risk factor for disease progression.

More Related Videos

In-vitro Reconstitution of Bacterial Ubiquitination and VCP/p97-mediated Elimination
07:58

In-vitro Reconstitution of Bacterial Ubiquitination and VCP/p97-mediated Elimination

Published on: January 2, 2026

Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model
09:00

Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model

Published on: April 17, 2026

Related Experiment Videos

Last Updated: Jun 20, 2026

In Vitro Analysis of E3 Ubiquitin Ligase Function
06:06

In Vitro Analysis of E3 Ubiquitin Ligase Function

Published on: May 14, 2021

In-vitro Reconstitution of Bacterial Ubiquitination and VCP/p97-mediated Elimination
07:58

In-vitro Reconstitution of Bacterial Ubiquitination and VCP/p97-mediated Elimination

Published on: January 2, 2026

Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model
09:00

Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model

Published on: April 17, 2026

Area of Science:

  • Biochemistry
  • Neuroscience
  • Molecular Biology

Background:

  • Neurodegenerative disorders share common features like protein misfolding, aggregation, and metal ion dysregulation.
  • Ubiquitin, crucial for protein degradation, is found in protein aggregates but its aggregation propensity is understudied.
  • Copper ions (Cu(II)) are known to compromise ubiquitin stability and bind to its N-terminus.

Purpose of the Study:

  • To investigate the role of copper in ubiquitin aggregation.
  • To characterize the structures formed by copper-induced ubiquitin aggregates.
  • To assess the potential implications of these aggregates in neurodegenerative diseases.

Main Methods:

  • Incubation of ubiquitin with Cu(II) in aqueous and mixed solvent systems.
  • Spectroscopic analysis (Circular Dichroism, FTIR) to monitor structural changes.
  • Microscopy techniques (AFM, TEM) for structural characterization.
  • Liposome and bilayer reconstitution assays.

Main Results:

  • Cu(II) induces the formation of SDS-resistant spherical ubiquitin oligomers in water.
  • In a membrane-mimicking environment, Cu(II) promotes the formation of beta-sheet-rich aggregates with complex structures (chains, rings, networks).
  • These aggregates are not amyloidogenic and disassemble upon copper chelation or reduction.
  • Reconstitution into liposomes and bilayers reveals annular and pore-like structures.

Conclusions:

  • Copper binding significantly promotes ubiquitin aggregation, leading to the formation of oligomers and larger structures.
  • The observed structures, particularly pore-like formations in membranes, resemble toxic species implicated in neurodegenerative diseases.
  • Ubiquitin's susceptibility to copper-induced aggregation may represent a novel risk factor in the pathogenesis of neurodegenerative disorders.